<p>Nuclear medicine, despite its pivotal role in precision diagnostics and theranostics, faces a significant recruitment crisis across Europe—most acutely in Italy, where over 73% of residency positions remained vacant in 2024. This shortage extends beyond physicians to encompass the entire nuclear medicine workforce, including radiopharmacists, technologists, cyclotron operators, and physicists. Multiple factors contribute to this trend: societal unease with the term “nuclear,” limited undergraduate exposure, regulatory emphasis on radiation risk over clinical benefit, perceived complexity of the discipline, gender-related concerns, and the ambiguous relationship between nuclear medicine and radiology. Misconceptions—often reinforced by minimal clinical visibility and underdeveloped mentorship—further diminish its appeal to medical graduates. To address this, educational reform is needed to integrate structured rotations, interdepartmental collaboration, and active mentorship, while strategic communication should highlight the specialty’s expanding therapeutic role, workplace safety, and career security. Modular training pathways and targeted marketing of nuclear medicine’s innovation, societal impact, and multidisciplinary opportunities could realign workforce interest with the specialty’s rapid technological and clinical evolution. Without immediate action, the field risks losing momentum at a time of unprecedented scientific and therapeutic potential.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Leading the theranostic revolution: addressing the recruitment crisis in European nuclear medicine

  • Arosh S. Perera Molligoda Arachchige

摘要

Nuclear medicine, despite its pivotal role in precision diagnostics and theranostics, faces a significant recruitment crisis across Europe—most acutely in Italy, where over 73% of residency positions remained vacant in 2024. This shortage extends beyond physicians to encompass the entire nuclear medicine workforce, including radiopharmacists, technologists, cyclotron operators, and physicists. Multiple factors contribute to this trend: societal unease with the term “nuclear,” limited undergraduate exposure, regulatory emphasis on radiation risk over clinical benefit, perceived complexity of the discipline, gender-related concerns, and the ambiguous relationship between nuclear medicine and radiology. Misconceptions—often reinforced by minimal clinical visibility and underdeveloped mentorship—further diminish its appeal to medical graduates. To address this, educational reform is needed to integrate structured rotations, interdepartmental collaboration, and active mentorship, while strategic communication should highlight the specialty’s expanding therapeutic role, workplace safety, and career security. Modular training pathways and targeted marketing of nuclear medicine’s innovation, societal impact, and multidisciplinary opportunities could realign workforce interest with the specialty’s rapid technological and clinical evolution. Without immediate action, the field risks losing momentum at a time of unprecedented scientific and therapeutic potential.